NPA Coacervates for Macromolecular Segregation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional synthetic coacervates fail to maintain long-term stability and spatiotemporal macromolecular heterogeneity due to rapid diffusional exchange with the surrounding solution, lacking the necessary attributes of high size uniformity and controlled macromolecular segregation, which are crucial for creating a stable 3D cellular microenvironment.

Innovation Solution

The development of nanoparticle-assembled (NPA) coacervates through non-covalent bonding-driven in-situ self-assembly of core-shell nanoparticles with hydrophobic cores and hydrophilic chains, which exhibit low size polydispersity and restrict macromolecular exchange, allowing for controlled spatiotemporal distribution of macromolecules and cellular regulation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If conventional synthetic coacervates are used, then macromolecular encapsulation is achieved, but rapid diffusional exchange with surrounding solution occurs leading to loss of spatiotemporal heterogeneity

Engineering Contradiction:
Improvemacromolecular encapsulationVSAvoidspatiotemporal heterogeneity
Core Design Contradiction:
Quantity of substanceVSStability of the object's composition

Solution Approach 1:

The patent divides the coacervate structure into multiple liquid phases with different viscosities and macromolecular concentrations. The segmented structure creates distinct compartments that restrict diffusional exchange while maintaining encapsulation, resolving the contradiction between substance quantity and compositional stability.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent creates regions with different physical and chemical properties within the coacervate, including varying macromolecular concentrations and viscosities. This local quality differentiation establishes barriers to diffusion in specific regions while maintaining overall encapsulation, thereby preserving spatiotemporal heterogeneity.

Inventive Principle:
Principle #3Local quality

2Ease of manufacture

If homogeneous synthetic coacervates are used, then simplified phase-separated systems are formed, but macromolecular diffusion barriers are insufficient

Engineering Contradiction:
Improvephase-separated system formationVSAvoidmacromolecular diffusion barrier
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent introduces local quality variations by creating multilayered structures with different liquid phases, each having distinct macromolecular concentrations and viscosities. This maintains relative ease of manufacture through phase separation while significantly enhancing macromolecular diffusion barriers through the heterogeneous architecture.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent constructs composite coacervate systems combining multiple liquid phases with different properties. This composite structure achieves both manufacturability through phase separation and reliable macromolecular diffusion barriers through the heterogeneous composition of different liquid phases.

Inventive Principle:
Principle #40Composite materials

3Manufacturing precision

If vacuolated coacervates are formed, then macromolecular segregation is improved, but vacuoles coalesce or are excluded from liquid coacervates

Engineering Contradiction:
Improvemacromolecular segregationVSAvoidvacuole stability
Core Design Contradiction:
Manufacturing precisionVSStability of the object's composition

Solution Approach 1:

The patent applies local quality differentiation by creating specific interface properties between vacuoles and the surrounding liquid coacervate phase. This prevents coalescence and exclusion while maintaining the segregative function of vacuoles, thereby achieving both manufacturing precision and compositional stability.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent stabilizes vacuoles beforehand through specific formulation and interface engineering, preventing coalescence and exclusion issues before they occur. This prior cushioning approach maintains vacuole integrity while preserving their macromolecular segregation function.

Inventive Principle:
Principle #11Beforehand cushioning (Prior cushioning)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

NPA coacervates provide stable, compartmentalized microenvironments with enhanced macromolecular segregation and controlled diffusion, supporting long-term cellular functions and modulating cellular behaviors by maintaining macromolecular heterogeneity and facilitating reversible transitions between vacuolated and hydrogel states.

Implementation Method 1

non-covalent bonding-driven in-situ self-assembly of core-shell nanoparticles

Methodology Applied
Scientific EffectNon-covalent bonding: Chemical Bonding

Implementation Method 2

non-covalent bonding-driven in-situ self-assembly of core-shell nanoparticles

Methodology Applied
Scientific EffectSelf-assembly: Self-Assembly

Implementation Method 3

electrostatically driven fluid-fluid phase separation of complexed polyelectrolytes

Methodology Applied
Scientific EffectPhase separation: Liquid-Liquid Extraction

Implementation Method 4

core-shell nanoparticles with hydrophobic cores and hydrophilic chains

Methodology Applied
Scientific EffectHydrophobic effect: Hydrophobe

Implementation Method 5

restrict the diffusional exchange of macromolecules with the surrounding liquid phase

Methodology Applied
Scientific EffectDiffusion restriction: Diffusion Barrier

Data Source

PatentUS20210283064A1Stable, bioadhesive, and diffusion-restrictive coacervate
Publication Date: 2021.09.16 THE CHINESE UNIVERSITY OF HONG KONG
  • US20210283064A1 patent drawing
  • US20210283064A1 patent drawing
  • US20210283064A1 patent drawing

AI summary

Provided herein are nanoparticle assembled (NPA) coacervates, the nanoparticles of which each include a hydrophobic core and a plurality of hydrophilic polymeric chains extending from the hydrophobic core. The hydrophilic chains include functional end groups capable of non-covalent interactions with one another upon assembly of the nanoparticles into the coacervates. Also provided are methods for forming the coacervates, reversibly switching the physiological states of the coacervates, transiently activating macromolecular uptake by the coacervates, and administering the coacervates to a subject.